Optum Insight (Clinformatics DataMart) Data Acquisition

Optum Insight（Clinformatics DataMart）数据采集

• 批准号: 10495329
• 负责人: CLIFF WHITE
• 金额: $ 25万
• 依托单位: QUALITYMETRIC, INC.
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-09-27 至 2022-09-26
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10495329
• 关键词: Blinded; Characteristics; Complement; Contracts; Cost Savings; Data; Data Mart; Data Sources; Disease; Electronic Health Record; Enrollment; Epidemiology; Health; Insurance; Laboratories; Link; Medicaid; Medical; Medicare; Medicare Part C; Minority Groups; National Health and Nutrition Examination Survey; National Institute of Diabetes and Digestive and Kidney Diseases; Patients; Population; Privatization; Prognosis; Recording of previous events; Records; Source; Surveys; Test Result; United States National Center for Health Statistics; data acquisition; insight; interest; longitudinal analysis; member; patient health information; patient population; patient privacy; pharmacy benefit; statistics

NIDDK epidemiology contracts provide a compendium of vital information on the burden, characteristics and prognosis of diseases of interest to the various divisions. In order to provide meaningful information to stakeholders, a variety of data sources are required. These include various NCHS sources including NHANES, a nationally representative survey conducted by NCHS; CMS data obtained directly from CMS, which demographically represents an older, more likely retired, and disproportionately minority population. More recently, private insurance data, such as Optum Insight, which provides information on a younger, more likely employed population, and thus complementary and providing a more fully representative population than CMS data alone, has been obtained. In the most recent iteration of the contact last year, various members of the acquisition planning team recommended acquisition of Optum data be shared among various divisions, and potentially even other IC’s, as an efficient and cost saving strategy. Optum Insight is a company of United Health Group. It provides an integrated enrollment, medical and prescription claims data augmented with laboratory test results data. It only members with both medical and pharmacy benefits. Includes UHC fully insured, Medicaid, and legacy Medicare Choice membership and claims. Blinded data to protect patient privacy, yet supports patient-linked longitudinal analysis. CDM Statistics May 2000 through June 2012 (10+ years of history) 61 million membership records 50 million unique members Roughly 14 million covered lives per year

NIDDK的流行病学合同提供了各部门感兴趣的疾病的负担、特征和预后的重要信息简编。为了向利益攸关方提供有意义的信息，需要各种数据来源。这些包括各种NCHS来源，包括NHANES，NCHS进行的全国代表性调查;直接从CMS获得的CMS数据，从人口统计学上代表老年人，更有可能退休，不成比例的少数民族人口。最近，获得了Optum Insight等私人保险数据，提供了关于更年轻、更有可能就业的人口的信息，从而起到补充作用，比CMS单独提供的数据更具有代表性。在去年的最新一次接触中，收购规划团队的多名成员建议在各部门甚至其他IC之间共享Optum数据的收购，作为一种有效和节省成本的策略。Optum Insight是United Health Group的子公司。它提供了一个综合的登记，医疗和处方索赔数据与实验室测试结果数据增强。它只提供医疗和药房福利。包括UHC完全保险，Medicaid和传统Medicare Choice会员资格和索赔。盲态数据保护患者隐私，但支持与患者相关的纵向分析。 CDM统计 2000年5月至2012年6月（10年以上历史） 6100万条会员记录 5000万独立会员 每年覆盖约1400万人